Therefore, a primary aim of acromegaly management is to reach normal age-adjusted IGF-1 levels, as well as safe GH values (defined as random GH <1 μg/L or <2.5 μg/L, according to the sensitivity of the assays) [2,3]. This evidence concerns the gene GH1 and acromegaly.